FGF21 and metabolic dysfunction-associated steatotic liver disease: FGF21 is also a hepatokine with favorable metabolic effects, and it is seen to be upregulated in NAFLD, possibly as a compensatory reaction to hepatic lipid overload and oxidative stress [24].